Associations Between Gut Microbiota, Short-Chain Fatty Acids, and High-Salt Diet-Induced Hypertension in Rats

Abstract

Objective

Numerous studies have established a link between hypertension (HTN) and a high-salt diet (HSD). However, the precise mechanisms are still being investigated, with increasing evidence suggesting that HSD can alter the gut microbiome balance, influence the production of microbiome metabolites and potentially lead to high blood pressure, presenting a promising avenue for targeting specific microbiota in HTN treatment. Short-chain fatty acids (SCFAs) are produced by gut bacteria and are associated with blood pressure regulation. Thus, the relationships among HSD, SCFAs, and blood pressure could provide valuable information on the pathophysiology of HTN. This study aimed to assess the impact of HSD on HTN by investigating its influence on the gut microbiota composition and SCFA levels in a rat model of HTN.

Methods

The HTN rat model was constructed by placing the rats on HSD (8% NaCl) for 8 weeks. On the 8th week, fecal samples were collected from the rats for DNA extraction. The profile of the gut microbiota was subsequently evaluated through 16S rRNA sequencing. The fecal SCFAs were subsequently measured and analyzed.

Results

Analysis of 16S rRNA sequencing data revealed that consumption of HSD was associated with an increase in pathogenic bacteria, including Turicibacter and Clostridia_UCG-014, and a decrease in beneficial bacteria, including Bifidobacterium and Lactobacillus. Metabolomic analysis of fecal samples suggested that HSD could increase the concentrations of most SCFAs, except caproic acid. Notably, a significant correlation was observed through Spearman correlation analysis between SCFAs and the changes in the gut microbiota caused by HSD, leading to a direct effect on SCFA levels.

Conclusion

The alterations in the gut microbiota resulting from HSD impact the levels of SCFAs, potentially disrupting gut equilibrium and initiating HTN, thereby increasing susceptibility to cardiovascular disease and associated health complications.

Keywords

Hypertension / Gut microbiota / High-salt diet / Short-chain fatty acids

References

[1] ForouzanfarMH, LiuP, RothGA, et al.. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA., 2017, 317(2): 165-182.

[2] HowardG, CushmanM, MoyCS, et al.. Association of clinical and social factors with excess hypertension risk in black compared with White US Adults. JAMA., 2018, 320(13): 1338-1348.

[3] JuraschekSP, MillerER3rd, WeaverCM, et al.. Effects of sodium reduction and the DASH diet in relation to baseline blood pressure. J Am Coll Cardiol., 2017, 70(23): 2841-2848.

[4] PushpakumarS, AhmadA, KetchemCJ, et al.. Sodium-hydrogen exchanger regulatory factor-1 (NHERF1) confers salt sensitivity in both male and female models of hypertension in aging. Life Sci., 2020, 243117226.

[5] MarquesFZ, MackayCR, KayeDM. Beyond gut feelings: how the gut microbiota regulates blood pressure. Nat Rev Cardiol., 2018, 15: 20-32.

[6] Pevsner-FischerM, BlacherE, TatirovskyE, et al.. The gut microbiome and hypertension. Curr Opin Nephrol Hypertens., 2017, 26(1): 1-8.

[7] SantistebanMM, QiY, ZubcevicJ, et al.. Hypertension-linked pathophysiological alterations in the gut. Circ Res., 2017, 120(2): 312-323.

[8] MarquesFZ, NelsonE, ChuPY, et al.. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation., 2017, 135(10): 964-977.

[9] YangT, SantistebanMM, RodriguezV, et al.. Gut dysbiosis is linked to hypertension. Hypertension., 2015, 65(6): 1331-1340.

[10] LiJ, ZhaoF, WangY, et al.. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome, 2017, 5114.

[11] WilckN, MatusMG, KearneySM, et al.. Salt-responsive gut commensal modulates T17 axis and disease. Nature., 2017, 551(7682): 585-589.

[12] KhalesiS, SunJ, BuysN, et al.. Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension., 2014, 64(4): 897-903.

[13] YanX, JinJ, SuX, et al.. Intestinal flora modulates blood pressure by regulating the synthesis of intestinal-derived corticosterone in high salt-induced hypertension. Circ Res., 2020, 126(7): 839-853.

[14] KohA, De VadderF, Kovatcheva-DatcharyP, et al.. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell., 2016, 165(6): 1332-1345.

[15] PluznickJL, ProtzkoRJ, GevorgyanH, et al.. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci USA, 2013, 110(11): 4410-4415.

[16] Robles-VeraI, ToralM, de la VisitaciónN, et al.. Probiotics prevent dysbiosis and the rise in blood pressure in genetic hypertension: role of short-chain fatty acids. Mol Nutr Food Res., 2020, 646. e1900616

[17] RappJP, DeneH. Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension., 1985, 7(3 Pt 1): 340-349.

[18] MatsuiH, ShimosawaT, UetakeY, et al.. Protective effect of potassium against the hypertensive cardiac dysfunction: association with reactive oxygen species reduction. Hypertension., 2006, 48(2): 225-231.

[19] BjørkhaugST, AanesH, NeupaneSP, et al.. Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption. Gut Microbes., 2019, 10(6): 663-675.

[20] MagočT, SalzbergSL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics., 2011, 27(21): 2957-2963.

[21] CaporasoJG, KuczynskiJ, StombaughJ, et al.. QIIME allows analysis of high-throughput community sequencing data. Nat Methods., 2010, 7(5): 335-336.

[22] BokulichNA, SubramanianS, FaithJJ, et al.. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat Methods., 2013, 10(1): 57-59.

[23] EdgarRC, HaasBJ, ClementeJC, et al.. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics., 2011, 27(16): 2194-2200.

[24] EdgarRC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods., 2013, 10(10): 996-998.

[25] WestcottSL, SchlossPD. OptiClust, an improved method for assigning amplicon-based sequence data to operational taxonomic units. mSphere., 2017, 2(2): e00073-e117.

[26] ChenM, XuJ, DaiR, et al.. Development of a moving-bed electrochemical membrane bioreactor to enhance removal of low-concentration antibiotic from wastewater. Bioresour Technol., 2019, 293122022.

[27] ZhangL, WangY, XiayuX, et al.. Altered Gut Microbiota in a Mouse Model of Alzheimer’s Disease. J Alzheimers Dis., 2017, 60(4): 1241-1257.

[28] ZhengX, QiuY, ZhongW, et al.. A targeted metabolomic protocol for short-chain fatty acids and branched-chain amino acids. Metabolomics., 2013, 9(4): 818-827.

[29] LuWW, FuTX, WangQ, et al.. The effect of total glucoside of paeony on gut microbiota in NOD mice with Sjögren’s syndrome based on high-throughput sequencing of 16SrRNA gene. Chin Med., 2020, 1561.

[30] GomesA, OudotC, MaciàA, et al.. Berry-enriched diet in salt-sensitive hypertensive rats: metabolic fate of (poly)phenols and the role of gut microbiota. Nutrients., 2019, 11112634.

[31] OparilS, AcelajadoMC, BakrisGL, et al.. Hypertension. Nat Rev Dis Primers., 2018, 418014.

[32] DurganDJ, ZubcevicJ, Vijay-KumarM, et al.. Prospects for leveraging the microbiota as medicine for hypertension. Hypertension., 2024, 81(5): 951-963.

[33] WangP, ShenY, YanK, et al.. CKD patients comorbid with hypertension are associated with imbalanced gut microbiome. iScience., 2025, 282111766.

[34] RichardsEM, LiJ, StevensBR, et al.. Gut microbiome and neuroinflammation in hypertension. Circ Res., 2022, 130(3): 401-417.

[35] StojanovS, BerlecA, ŠtrukeljB. The influence of probiotics on the Firmicutes/Bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease. Microorganisms., 2020, 8111715.

[36] YangF, ChenH, GaoY, et al.. Gut microbiota-derived short-chain fatty acids and hypertension: mechanism and treatment. Biomed Pharmacother., 2020, 130110503.

[37] WangC, HuangZ, YuK, et al.. High-salt diet has a certain impact on protein digestion and gut microbiota: a sequencing and proteome combined study. Front Microbiol., 2017, 81838.

[38] JoeB, McCarthyCG, EdwardsJM, et al.. Microbiota introduced to germ-free rats restores vascular contractility and blood pressure. Hypertension., 2020, 76(6): 1847-1855.

[39] Gómez-GuzmánM, ToralM, RomeroM, et al.. Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats. Mol Nutr Food Res., 2015, 59(11): 2326-2336.

[40] YangZ, WangQ, LiuY, et al.. Gut microbiota and hypertension: association, mechanisms and treatment. Clin Exp Hypertens., 2023, 4512195135.

[41] GaoK, MuCL, FarziA, et al.. Tryptophan metabolism: a link between the gut microbiota and brain. Adv Nutr., 2020, 11(3): 709-723.

[42] ToralM, Robles-VeraI, de la VisitaciónN, et al.. Critical role of the interaction gut microbiota—sympathetic nervous system in the regulation of blood pressure. Front Physiol., 2019, 10231.

[43] VaccaM, CelanoG, CalabreseFM, et al.. The controversial role of human gut Lachnospiraceae. Microorganisms., 2020, 84573.

[44] BierA, BraunT, KhasbabR, et al.. A high salt diet modulates the gut microbiota and short chain fatty acids production in a salt-sensitive hypertension rat model. Nutrients., 2018, 1091154.

[45] AdnanS, NelsonJW, AjamiNJ, et al.. Alterations in the gut microbiota can elicit hypertension in rats. Physiol Genomics., 2017, 49(2): 96-104.

[46] MellB, JalaVR, MathewAV, et al.. Evidence for a link between gut microbiota and hypertension in the Dahl rat. Physiol Genomics., 2015, 47(6): 187-197.

[47] MirandaPM, De PalmaG, SerkisV, et al.. High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production. Microbiome., 2018, 6157.

[48] HuartJ, LeendersJ, TaminiauB, et al.. Gut microbiota and fecal levels of short-chain fatty acids differ upon 24-hour blood pressure levels in men. Hypertension., 2019, 74(4): 1005-1013.

[49] ChenL, HeFJ, DongY, et al.. Modest sodium reduction increases circulating short-chain fatty acids in untreated hypertensives: a randomized, double-blind placebo-controlled trial. Hypertension., 2020, 76(1): 73-79.

[50] TilvesC, YehHC, MaruthurN, et al.. Increases in circulating and fecal butyrate are associated with reduced blood pressure and hypertension: results from the SPIRIT Trial. J Am Heart Assoc., 2022, 1113. e024763

[51] BartolomaeusH, BaloghA, YakoubM, et al.. Short-chain fatty acid propionate protects from hypertensive cardiovascular damage. Circulation., 2019, 139(11): 1407-1421.

[52] YamamuraR, NakamuraK, KitadaN, et al.. Associations of gut microbiota, dietary intake, and serum short-chain fatty acids with fecal short-chain fatty acids. Biosci Microbiota Food Health., 2020, 39(1): 11-17.

[53] FaracoG, HochrainerK, SegarraSG, et al.. Dietary salt promotes cognitive impairment through tau phosphorylation. Nature., 2019, 574(7780): 686-690.

[54] WuQ, BurleyG, LiLC, et al.. The role of dietary salt in metabolism and energy balance: Insights beyond cardiovascular disease. Diabetes Obes Metab., 2023, 25(5): 1147-1161.

[55] MutchlerSM, KiraboA, KleymanTR. Epithelial sodium channel and salt-sensitive hypertension. Hypertension., 2021, 77(3): 759-767.

[56] O’DonnellJA, ZhengT, MericG, et al.. The gut microbiome and hypertension. Nat Rev Nephrol., 2023, 19(3): 153-167.

[57] AveryEG, BartolomaeusH, MaifeldA, et al.. The gut microbiome in hypertension: recent advances and future perspectives. Circ Res., 2021, 128(7): 934-950.

[58] ChakrabortyS, GallaS, ChengX, et al.. Salt-responsive metabolite, β-hydroxybutyrate attenuates hypertension. Cell Rep., 2018, 25(3): 677-689.e4.

[59] NaqviS, AsarTO, KumarV, et al.. A cross-talk between gut microbiome, salt and hypertension. Biomed Pharmacother., 2021, 134111156.

[60] LiuK, XiB, LiuZ, et al.. Genetic predisposition and salt sensitivity in a Chinese Han population: the EpiSS study. Int J Hypertens., 2020, 20203167875.

Funding

National Natural Science Foundation of China(82305092)

National Natural Science Foundation of Hunan(2023JJ30453)

National Natural Science Foundation of Changsha(kq2208185)

Hunan Youth Science and Technology Innovation Talent Project(2022RC1021)

Foundation of Hunan University of CM(Z2023XJYQ03)

RIGHTS & PERMISSIONS

The Author(s), under exclusive licence to Huazhong University of Science and Technology